Lamivudine Can Exert a Modest Antiviral Effect against Human Immunodeficiency Virus Type 1 Containing the M184V Mutation

Por Quan, Yudong, Brenner, Bluma G., Oliveira, Maureen, Wainberg, Mark A.
Publicado em 2003

Dolutegravir Resistance Mutation R263K Cannot Coexist in Combination with Many Classical Integrase Inhibitor Resistance Substitutions

Por Anstett, Kaitlin, Mesplede, Thibault, Oliveira, Maureen, Cutillas, Vincent, Wainberg, Mark A.
Publicado no J Virol (2015)

The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistanc...

Por Liang, Jiaming, Mesplède, Thibault, Oliveira, Maureen, Anstett, Kaitlin, Wainberg, Mark A.
Publicado no J Virol (2015)

The M184V Mutation in Reverse Transcriptase Can Delay Reversion of Attenuated Variants of Simian Immunodeficiency Virus

Por Whitney, James B., Oliveira, Maureen, Detorio, Mervi, Guan, Yongjun, Wainberg, Mark A.
Publicado em 2002

Natural Polymorphisms in the Human Immunodeficiency Virus Type 2 Protease Can Accelerate Time to Development of Resistance to Protease Inhibitors

Por Ntemgwa, Michel, Brenner, Bluma G., Oliveira, Maureen, Moisi, Daniela, Wainberg, Mark A.
Publicado em 2007

The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound

Por Wainberg, Mark, Anstett, Kaitlin, Mesplede, Thibault, Quashie, Peter, Han, Yingshan, Oliveira, Maureen
Publicado no J Int AIDS Soc (2014)

Pressure of Zidovudine Accelerates the Reversion of Lamivudine Resistance-Conferring M184V Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1

Por Diallo, Karidia, Oliveira, Maureen, Moisi, Daniela, Brenner, Bluma, Wainberg, Mark A., Götte, Matthias
Publicado em 2002

Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C

Por Moisi Daniella, Oliveira Maureen, Asahchop Eugene, Quan Yudong, Xu Hong-Tao, Wainberg Mark A
Publicado em 2010-10-01

Differential Maintenance of the M184V Substitution in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 by Various Nucleoside Antiretroviral Agents in Tissue Culture

Por Petrella, Marco, Oliveira, Maureen, Moisi, Daniela, Detorio, Mervi, Brenner, Bluma G., Wainberg, Mark A.
Publicado em 2004

Apricitabine Does Not Select Additional Drug Resistance Mutations in Tissue Culture in Human Immunodeficiency Virus Type 1 Variants Containing K65R, M184V, or M184V plus Thymidine...

Por Oliveira, Maureen, Moisi, Daniela, Spira, Bonnie, Cox, Susan, Brenner, Bluma G., Wainberg, Mark A.
Publicado em 2009

Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C

Por Xu, Hong-Tao, Quan, Yudong, Asahchop, Eugene, Oliveira, Maureen, Moisi, Daniella, Wainberg, Mark A
Publicado em 2010

HIV-1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV-1 group M

Por Depatureaux, Agnès, Mesplède, Thibault, Quashie, Peter, Oliveira, Maureen, Moisi, Daniela, Brenner, Bluma, Wainberg, Mark
Publicado no J Int AIDS Soc (2014)

Dolutegravir maintains a durable effect against HIV replication in tissue culture even after drug washout

Por Osman, Nathan, Mesplède, Thibault, Quashie, Peter K., Oliveira, Maureen, Zanichelli, Veronica, Wainberg, Mark A.
Publicado no J Antimicrob Chemother (2015)

The M184V Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Delays the Development of Resistance to Amprenavir and Efavirenz in Subtype B and C Clinical Iso...

Por Diallo, Karidia, Brenner, Bluma, Oliveira, Maureen, Moisi, Daniela, Detorio, Mervi, Götte, Matthias, Wainberg, Mark A.
Publicado em 2003

Biochemical and virological analysis of the preference for the K65R multi-resistance nucleoside mutation in subtype C viruses

Por Wainberg, Mark A, Invernizzi, Cédric F, Coutsinos, Dimitrios, Oliveira, Maureen, Moisi, Daniela, Brenner, Bluma G
Publicado em 2009

Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to Zid...

Por Ntemgwa, Michel, Wainberg, Mark A., Oliveira, Maureen, Moisi, Daniela, Lalonde, Richard, Micheli, Valeria, Brenner, Bluma G.
Publicado em 2007

HIV-1 Protease Codon 36 Polymorphisms and Differential Development of Resistance to Nelfinavir, Lopinavir, and Atazanavir in Different HIV-1 Subtypes

Por Lisovsky, Irene, Schader, Susan M., Martinez-Cajas, Jorge-Luis, Oliveira, Maureen, Moisi, Daniela, Wainberg, Mark A.
Publicado em 2010

The M230L Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation in HIV-1 Reverse Transcriptase Impairs Enzymatic Function and Viral Replicative Capacity

Por Xu, Hong-Tao, Quan, Yudong, Schader, Susan M., Oliveira, Maureen, Bar-Magen, Tamara, Wainberg, Mark A.
Publicado em 2010

Effects of the W153L Substitution in HIV Reverse Transcriptase on Viral Replication and Drug Resistance to Multiple Categories of Reverse Transcriptase Inhibitors

Por Xu, Hong-Tao, Colby-Germinario, Susan P., Oliveira, Maureen, Rajotte, Daniel, Bethell, Richard, Wainberg, Mark A.
Publicado em 2014

Effect of HIV-1 Integrase Resistance Mutations When Introduced into SIVmac239 on Susceptibility to Integrase Strand Transfer Inhibitors

Por Hassounah, Said A., Mesplède, Thibault, Quashie, Peter K., Oliveira, Maureen, Sandstrom, Paul A., Wainberg, Mark A.
Publicado em 2014